Massive new study aims to stop Post-Surgery confusion in seniors

NCT ID NCT04355195

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study tests a structured care program to prevent postoperative delirium (sudden confusion) in patients aged 70 and older undergoing surgery. Over 18,000 participants will receive evidence-based prevention measures, with electronic tracking to ensure consistency. Additional sub-studies explore how blood pressure changes and brain wave monitoring might predict delirium risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
structured care program (evidence-based prevention measures, electronic documentation, and monitoring devices)
What this could lead to
If successful, this could establish a practical, hospital-wide approach to reduce postoperative delirium in older patients, improving recovery and quality of life.
What could go wrong
This is an implementation study, not a drug trial, so benefits depend on hospital staff following the program consistently. The sub-studies are exploratory and may not yield clear results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM IN OLD AGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Anesthesiology and Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin

    RECRUITING

    Berlin, 12203, Germany

  • Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) Berlin, Carité - Universitätsmedizin Berlin

    RECRUITING

    Berlin, 13353, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.